1,901
Views
4
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population

, ORCID Icon, , ORCID Icon, ORCID Icon, , & ORCID Icon show all
Pages 550-562 | Received 16 Dec 2020, Accepted 30 Mar 2021, Published online: 08 May 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.